![]() The need for high-quality biological materials to support cutting-edge disease research and development is constantly growing. PeproTech recombinant cytokines and proteins for life science research through clinical development. The deal represents the first act of M&A in 2021 for Thermo Fisher, which has grown into one of the largest life sciences services firms through its aggressive acquisition strategy.
0 Comments
Leave a Reply. |